More positive press for GALE and its Neuvax vaccine and substantial market for it.
"Galena Biopharma, Inc. (NASDAQ:GALE) is working on its breast cancer vaccine, NeuVax, which has entered into Phase III trials. If successful, this vaccine would not only help prevent millions of deaths caused by breast cancer, it would also delay the progression of damage caused by breast cancer. Below, I will examine Galena Biopharma (GALE) as an investment candidate in the context of the prevalence of breast cancer worldwide, the viability of vaccines in preventing and treating breast cancer, and discuss the company’s NeuVax vaccine and how it could be a long-term growth catalyst for its stock......."
Go GALE! I think it's about to rocket, lots of buying pressure, even on a Friday.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.